
The FDA grants accelerated approval to neladalkib for pretreated ALK-positive lung cancer, showing how next-gen kinase inhibitors tackle drug resistance
Considered "the premier annual homecoming event for the global pharma community," the 2025 theme is "Embracing Change: Catalysts for Disruption."
Dates: April 6–11, 2025
Location: Palm Springs, Calif.
Description: Parenteral Drug Association (PDA) Week 2025 offers attendees the opportunity to deepen their professional skills and expertise, experience cutting-edge science and practices, and do a deep dive into hands-on training courses, immersive workshops, mini-workshops, and mini-training courses.
Registration:






